A high-throughput chemical screen with FDA approved drugs reveals that the antihypertensive drug Spironolactone impairs cancer cell survival by inhibiting homology directed repair
Or David Shahar, Alkmini Kalousi, Lital Eini, Benoit Fisher, Amélie Weiss, Jonatan Darr, Olga Mazina, Shay Bramson, Martin Kupiec, Amir Eden, Eran Meshorer, Alexander V. Mazin, Laurent Brino, Michal Goldberg, Evi Soutoglou